The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma

Summary

The investigators want to assess the safety and efficacy of using intralesional 5-FU for the management of different types of BCC (including all the types EXCEPT the infiltrative one), by estimating different outcomes after the intralesional administration of 5-FU to BCC patient. Patients are randomly selected from the outpatient dermatologic clinic in the Aleppo University Hospital (AUH) over a period of 12 months and then these patients are followed up over another 12 months.

Timeline

Start

2023-05-25

Primary completion

2025-05-25

Completion

2025-05-25

Drugs

Indications